| |
| |
|
| Insider
Information: |
Berstein David L |
| Relationship: |
SVP, Chief IP Counsel |
| City: |
Cambridge |
| State: |
MA |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
1 |
|
| Direct
Shares |
262,115 |
|
|
Indirect Shares
|
0 |
|
|
| Direct
Value |
$0 |
|
|
|
Indirect Value
|
$0 |
|
|
| Total
Shares |
262,115 |
|
|
| Total
Value |
$0 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
0
|
0
|
|
Stock
price went up :
|
0
|
0
|
| Stock
price went down : |
0
|
0
|
| |
|
|
|
Gain/Loss Ratio : |
0.0
|
0.0
|
| Percentage
Gain/Loss : |
0.0%
|
0.0%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Ariad Pharmaceuticals Inc |
ARIA |
SVP, Chief IP Counsel |
2016-03-21 |
262,115 |
2003-09-16 |
0 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
76 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 1 of 4
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| ARIA |
Ariad Pharmaceuticals Inc |
officerTitle |
• – – |
2003-09-16 |
4 |
OE |
$2.00 |
$64,286 |
D/D |
32,143 |
38,722 |
|
- |
|
| ARIA |
Ariad Pharmaceuticals Inc |
officerTitle |
• – – |
2003-09-24 |
4 |
S |
$7.00 |
$225,001 |
D/D |
(32,143) |
12,182 |
|
- |
|
| ARIA |
Ariad Pharmaceuticals Inc |
Senior VP Chief Patent Counsel |
• – – |
2004-01-07 |
4 |
OE |
$2.00 |
$7,142 |
D/D |
3,571 |
15,753 |
|
- |
|
| ARIA |
Ariad Pharmaceuticals Inc |
Senior VP Chief Patent Counsel |
• – – |
2004-08-11 |
4 |
OE |
$1.60 |
$20,000 |
D/D |
12,500 |
0 |
|
- |
|
| ARIA |
Ariad Pharmaceuticals Inc |
Senior VP Chief Patent Counsel |
• – – |
2004-08-12 |
4 |
OE |
$0.75 |
$78,460 |
D/D |
74,500 |
102,753 |
|
- |
|
| ARIA |
Ariad Pharmaceuticals Inc |
Senior VP, Chief IP Officer |
• – – |
2008-10-12 |
4 |
A |
$0.00 |
$0 |
D/D |
28,570 |
131,323 |
0 |
- |
|
| ARIA |
Ariad Pharmaceuticals Inc |
Senior VP, Chief IP Officer |
• – – |
2011-03-22 |
4 |
OE |
$0.00 |
$0 |
D/D |
26,334 |
190,419 |
0 |
- |
|
| ARIA |
Ariad Pharmaceuticals Inc |
Senior VP, Chief IP Officer |
• – – |
2011-03-22 |
4 |
D |
$6.39 |
$54,373 |
D/D |
(8,509) |
181,910 |
0 |
- |
|
| ARIA |
Ariad Pharmaceuticals Inc |
Senior VP, Chief IP Officer |
• – – |
2011-04-11 |
4 |
D |
$7.76 |
$54,204 |
D/D |
(6,985) |
198,801 |
0 |
- |
|
| ARIA |
Ariad Pharmaceuticals Inc |
Senior VP, Chief IP Officer |
• – – |
2011-04-11 |
4 |
OE |
$0.00 |
$0 |
D/D |
22,000 |
205,786 |
0 |
- |
|
| ARIA |
Ariad Pharmaceuticals Inc |
Senior VP, Chief IP Officer |
• – – |
2011-06-07 |
4 |
OE |
$5.65 |
$339,000 |
D/D |
60,000 |
258,801 |
0 |
- |
|
| ARIA |
Ariad Pharmaceuticals Inc |
Senior VP, Chief IP Officer |
• – – |
2011-06-07 |
4 |
D |
$8.65 |
$381,854 |
D/D |
(44,145) |
214,656 |
0 |
- |
|
| ARIA |
Ariad Pharmaceuticals Inc |
Senior VP, Chief IP Officer |
• – – |
2012-02-21 |
4 |
OE |
$3.90 |
$88,920 |
D/D |
22,800 |
237,456 |
0 |
- |
|
| ARIA |
Ariad Pharmaceuticals Inc |
Senior VP, Chief IP Officer |
• – – |
2012-02-21 |
4 |
AS |
$14.50 |
$509,032 |
D/D |
(35,100) |
202,356 |
0 |
- |
|
| ARIA |
Ariad Pharmaceuticals Inc |
Senior VP, Chief IP Officer |
• – – |
2012-02-28 |
4 |
AS |
$15.50 |
$176,313 |
D/D |
(11,375) |
198,256 |
0 |
- |
|
| ARIA |
Ariad Pharmaceuticals Inc |
Senior VP, Chief IP Officer |
• – – |
2012-02-28 |
4 |
OE |
$3.90 |
$44,703 |
D/D |
11,375 |
209,631 |
0 |
- |
|
| ARIA |
Ariad Pharmaceuticals Inc |
Senior VP, Chief IP Officer |
• – – |
2012-03-19 |
4 |
OE |
$0.00 |
$0 |
D/D |
47,000 |
245,256 |
0 |
- |
|
| ARIA |
Ariad Pharmaceuticals Inc |
Senior VP, Chief IP Officer |
• – – |
2012-03-20 |
4 |
S |
$15.02 |
$282,314 |
D/D |
(18,800) |
226,456 |
0 |
- |
|
| ARIA |
Ariad Pharmaceuticals Inc |
Senior VP, Chief IP Officer |
• – – |
2012-03-22 |
4 |
OE |
$0.00 |
$0 |
D/D |
26,333 |
252,789 |
0 |
- |
|
| ARIA |
Ariad Pharmaceuticals Inc |
Senior VP, Chief IP Officer |
• – – |
2012-03-23 |
4 |
AS |
$15.41 |
$162,274 |
D/D |
(10,533) |
242,256 |
0 |
- |
|
| ARIA |
Ariad Pharmaceuticals Inc |
Senior VP, Chief IP Officer |
• – – |
2012-03-26 |
4 |
OE |
$4.19 |
$47,661 |
D/D |
11,375 |
253,631 |
0 |
- |
|
| ARIA |
Ariad Pharmaceuticals Inc |
Senior VP, Chief IP Officer |
• – – |
2012-03-26 |
4 |
AS |
$16.00 |
$182,000 |
D/D |
(11,375) |
242,256 |
0 |
- |
|
| ARIA |
Ariad Pharmaceuticals Inc |
Senior VP, Chief IP Officer |
• – – |
2012-05-02 |
4 |
OE |
$4.19 |
$47,661 |
D/D |
11,375 |
257,231 |
0 |
- |
|
| ARIA |
Ariad Pharmaceuticals Inc |
Senior VP, Chief IP Officer |
• – – |
2012-05-02 |
4 |
AS |
$17.00 |
$329,375 |
D/D |
(19,375) |
237,856 |
0 |
- |
|
| ARIA |
Ariad Pharmaceuticals Inc |
Senior VP, Chief IP Officer |
• • – |
2012-07-30 |
4 |
AS |
$19.00 |
$152,000 |
D/D |
(8,000) |
221,856 |
0 |
- |
|
76 Records found
|
|
Page 1 of 4 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
